An interview between Dr. Brittney Schultz and Becky Strong, IPPF Outreach Director, was published by the Women's Dermatological Society on June 27, 2022 and highlights the importance and value for physicians...
Highly accurate IIF serological assay for Laminin 332 Mucous Membrane Pemphigoid reduces the wait for confirmed diagnosis from months or years to 72 hours or less On July 27, 2022 KSL...
The following was published on May 25, 2022 in Practical Dermatology. The Global Dermatology Coalition, a patient-led, multi-stakeholder group of organizations, has launched during the 75th World Health Assembly in Geneva. The Global...
The following Letter to the Editor was published in the Journal of the European Academy of Dermatology and Venereology on April 25, 2022 about the role of the IPPF during...
Akari Therapeutics recently announced that positive results from the Phase II study of investigational nomacopan in bullous pemphigoid (BP) were published online in the Journal of the American Medical Association (JAMA). ...
The following was published as a Letter to the Editor in the British Journal of Dermatology in November, 2021. The letter outlines a cross-sectional study of COVID-19 vaccine acceptance and...
